| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2023 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Unknown transaction of 22,242 shares
@ $0
Disposed/sold 23,700 options to buy
@ $34.88, valued at
$826.7k
Disposed/sold 31,500 options to buy
@ $24.67, valued at
$777.1k
Disposed/sold 37,500 options to buy
@ $28.76, valued at
$1.1M
Disposed/sold 75,513 restricted stock units
@ $0 |
|
| 01/27/2023 |
4/A
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 55,000 shares
@ $0 |
|
| 01/25/2023 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 55,000 shares
@ $0 |
|
| 01/23/2023 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 102 shares
@ $43.8, valued at
$4.5k
|
|
| 01/20/2023 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 1,774 shares
@ $43.9044, valued at
$77.9k
|
|
| 01/09/2023 |
4/A
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 469 shares
@ $19.0614, valued at
$8.9k
|
|
| 01/09/2023 |
4/A
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 106 shares
@ $24.6713, valued at
$2.6k
|
|
| 10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2022 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 445 shares
@ $19.4049, valued at
$8.6k
|
|
| 07/25/2022 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 106 shares
@ $24.6713, valued at
$2.6k
|
|
| 06/28/2022 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 461 shares
@ $19.47, valued at
$9k
|
|
| 06/16/2022 |
4
| Stephenson Pamela (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 23,109 shares
@ $0
Sold 40 shares
@ $1.01, valued at
$40.4
Granted 34,663 options to buy
@ $1.01, valued at
$35k
|
|
| 04/25/2022 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 103 shares
@ $32.9247, valued at
$3.4k
|
|
| 03/29/2022 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 454 shares
@ $30.525, valued at
$13.9k
|
|
| 01/25/2022 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 416 shares
@ $24.8822, valued at
$10.4k
|
|
| 01/20/2022 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 21,600 shares
@ $0 |
|
| 12/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2021 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 451 shares
@ $32.0537, valued at
$14.5k
|
|
| 08/05/2021 |
4
| Stephenson Pamela (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 7,500 options to buy
@ $4.44, valued at
$33.3k
|
|
| 06/28/2021 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 471 shares
@ $36.01, valued at
$17k
|
|
| 03/31/2021 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 422 shares
@ $34.0174, valued at
$14.4k
|
|
| 01/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2020 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 460 shares
@ $39.0742, valued at
$18k
|
|
| 09/25/2020 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 451 shares
@ $33.2, valued at
$15k
|
|
| 06/26/2020 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 397 shares
@ $30.79, valued at
$12.2k
|
|
| 06/11/2020 |
4
| Stephenson Pamela (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $5.21, valued at
$78.2k
|
|
| 03/25/2020 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 1,785 shares
@ $17.6, valued at
$31.4k
|
|
| 01/23/2020 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 31,500 options to buy
@ $24.67, valued at
$777.1k
|
|
| 06/13/2019 |
4
| Stephenson Pamela (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $13.5, valued at
$202.5k
|
|
| 03/27/2019 |
4
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 25,000 shares
@ $0
Granted 37,500 options to buy
@ $28.76, valued at
$1.1M
|
|
| 03/27/2019 |
3
| Stephenson Pamela (Chief Commercial Officer) has filed a Form 3 on ALBIREO PHARMA, INC. |
| 02/20/2019 |
4
| Stephenson Pamela (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 35,000 options to buy
@ $5.03, valued at
$176.1k
|
|
| 02/20/2019 |
3
| Stephenson Pamela (Director) has filed a Form 3 on Zynerba Pharmaceuticals, Inc. |